<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04093011</url>
  </required_header>
  <id_info>
    <org_study_id>TedaICH-Thousands of plans</org_study_id>
    <nct_id>NCT04093011</nct_id>
  </id_info>
  <brief_title>Perioperative Outcome of Congenital Heart Disease Surgery in Childhood</brief_title>
  <official_title>Perioperative Outcome of Congenital Heart Disease Surgery in Childhood: Results From a Chinese Cross-regional Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital heart disease is the most common congenital malformation in the world with high
      morbidity and mortality. However, there is no data to assess the perioperative outcome of
      congenital heart disease surgery among Chinese cross-regional population. This study aims to
      investigate the perioperative outcome of congenital heart disease surgery in childhood from a
      chinese cross-regional cohort.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of systemic inflammatory response syndrome</measure>
    <time_frame>postoperative day 7 or hospital discharge, whichever occurred first.</time_frame>
    <description>Systemic inflammatory response syndrome was determined mainly on (i) Core temperature of &gt;38.5°C or &lt;36°C measured by rectal, oral, or central catheter probe; (ii) Tachycardia, defined as a mean heart rate &gt;2 SD above normal for age in the absence of external stimulus, chronic drugs, or painful stimuli; or otherwise unexplained persistent elevation over a 0.5- to 4-hr time period, or for children &lt;1 yr old: bradycardia, defined as a mean heart rate &lt;10th percentile for age in the absence of external vagal stimulus; or otherwise unexplained persistent depression over a 0.5-hr time period; (iii) Mean respiratory rate &gt;2 SD above normal for age, the prolonged mechanical ventilation defined as ventilation duration &gt; 48 hrs, or unplanned re-intubation for an acute process not related to underlying neuromuscular disease or the receipt of general anesthesia; (iv) Leukocyte count elevated or depressed for age or &gt;10% immature neutrophils.</description>
  </primary_outcome>
  <enrollment type="Anticipated">6500</enrollment>
  <condition>Congenital Heart Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Congenital Heart Disease Surgery</intervention_name>
    <description>Patients with congenital heart disease will undergo congenital heart disease surgery.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients aged 1 week-18 years underwent congenital heart disease surgery from different
        Chinese regions.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject was aged 1 week-18 years

          -  Subjects underwent congenital heart disease surgery;

          -  Available data to investigate perioperative outcome.

        Exclusion Criteria:

          -  Cardiac reoperation;

          -  Emergency surgery;

          -  Interventional procedure within prior 30 days prior to surgery;

          -  Missing outcome data.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Liu, MD</last_name>
    <role>Study Director</role>
    <affiliation>Peking Union Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hong Liu, MD</last_name>
    <email>DR.HONGLIU@FOXMAIL.COM</email>
  </overall_contact>
  <location>
    <facility>
      <name>TEDA International Cardiovascular Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300457</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Liu, MD</last_name>
      <phone>188012181613</phone>
      <email>dr.hongliu@foxmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 16, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College</investigator_affiliation>
    <investigator_full_name>Hong Liu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

